Cordlife Group Limited is an investment holding company engaged in the provision of cord blood banking services, which involves the processing and storage of stem cells. The Company operates as a consumer healthcare company. Its segments include Banking, Diagnostic and Others. The banking segment comprises cord blood and cord lining services. The diagnostics segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The Company also releases cord blood units for transplants, and for the treatment of cerebral palsy, as well as for other therapeutic uses. It has processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines.